FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...

Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been implanted worldwide.9,+ ...

GENEVA--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have been ...

Please provide your email address to receive an email when new articles are posted on . Over the course of the past decades, our IOL technology has continued to improve, particularly with the ability ...

Celebrating 75 years of intraocular lens advancements that have improved care for millions of cataract patients. On November 29, 1949, Sir Harold Ridley performed a surgical procedure to replace a ...

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...

enVista Envy is the first diffractive premium IOL from Bausch + Lomb available in Europe Offers a continuous range of vision with excellent dysphotopsia tolerance EyeGility™ delivery system ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (BLCO:CA), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for ...